Program
ciprofol
Also written as “HSK3486”, “Ciprofol” and “Cipepofol”.
Its studies are mostly in Arrhythmias, Cardiac · Renal Insufficiency, Chronic, led by Haisco Pharmaceutical Group.
Furthest: phase 4, since Aug 27, 202136 company-led studies, 2 open or runningNext primary completion: May 2028 (phase 3)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Haisco Pharmaceutical Group | 362 open or running | phase 4since Aug 27, 2021 | Sep 11, 2018 | May 2028phase 3 · NCT07510945 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 22 studies since Sep 11, 2018.
- Aug 11, 2020Phase 3 study in Induction and Maintenance of General AnesthesiaNCT04511728 · 129 enrolled · China
- Oct 21, 2020Phase 3 study in Sedation in Intensive CareNCT04620031 · 135 enrolled · China
- Nov 30, 2020Phase 2 study in Sedation in Intensive CareNCT04669821 · 20 enrolled · China
- Jan 12, 2021Phase 3 study in AnesthesiaNCT04711837 · 255 enrolled · United States
- Jun 23, 2021Phase 3 study in Gynecological Outpatient SurgeryNCT04958746 · 135 enrolled · China
- Aug 27, 2021Phase 4 study in Anesthesia, GeneralNCT05035069 · 24 enrolled · China
- Jul 22, 2022Phase 3 study in General AnesthesiaNCT05478174 · 400 enrolled · United States
- Aug 1, 2022Phase 3 study in General AnesthesiaNCT05486416 · 465 enrolled · United States, Poland, Spain
- Oct 12, 2022Phase 1 study in General AnesthesiaNCT05614544 · 42 enrolled · United States
- Apr 25, 2024Phase 3 study in AnesthesiaNCT06391931 · 190 enrolled · China
- Dec 13, 2024Phase 4 study in AnesthesiaNCT06740201 · 40 planned · China
- Jan 22, 2025Phase 1 study in Arrhythmias, CardiacNCT06795204 · 48 enrolled · China
- Feb 4, 2026Phase 1 study in General AnesthesiaNCT07404306 · 43 enrolled · United States
- Mar 29, 2026Phase 3 study in General AnestheticNCT07510945 · 400 planned
Ahead
- May 2028Primary completion: phase 3 study in General AnestheticNCT07510945
TargetBeta
GABRA1 →GABRA2 →GABRA3 →GABRA4 →GABRA5 →GABRA6 →GABRB1 →GABRB2 →GABRB3 →GABRD →GABRE →GABRG1 →GABRG2 →GABRG3 →GABRP →GABRQ →read by rule
“GABA-A receptor; anion channel agonist”ChEMBL 37, by rule
Other programs on the same 16 targets
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Midazolamrule | Pfizer | phase 4 | 96 |
| Alprazolamrule | Viatris | phase 4 | 35 |
| brexanolonerule | Supernus Pharmaceuticals | phase 4 | 14 |
| Diazepamrule | Acorda Therapeutics | phase 3 | 9 |
Studies
All 36 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07510945General Anesthetic | 3 | Not yet recruiting | May 2028 | 400 |
| NCT07404306General Anesthesia · United States | 1 | Completed | Oct 3, 2023 | 43 |
| NCT06795204Arrhythmias, Cardiac · China | 1 | Completed | May 19, 2024 | 48 |
| NCT06740201Anesthesia · China | 4 | Recruiting | Mar 30, 2025 | 40 |
| NCT06391931Anesthesia · China | 3 | Completed | Nov 6, 2024 | 190 |
| NCT05614544General Anesthesia · United States | 1 | Completed | Oct 3, 2023 | 42 |
| NCT05486416General Anesthesia · United States, Poland, Spain | 3 | Completed | Jul 23, 2024 | 465 |
| NCT05478174General Anesthesia · United States | 3 | Completed | Nov 7, 2023 | 400 |
| NCT05035069Anesthesia, General · China | 4 | UNKNOWN | Feb 3, 2022 | 24 |
| NCT04958746Gynecological Outpatient Surgery · China | 3 | Completed | Sep 29, 2021 | 135 |
| NCT04711837Anesthesia · United States | 3 | Completed | Apr 13, 2022 | 255 |
| NCT04669821Sedation in Intensive Care · China | 2 | Completed | Aug 28, 2021 | 20 |
| NCT04620031Sedation in Intensive Care · China | 3 | Completed | Jun 2, 2021 | 135 |
| NCT04511728Induction and Maintenance of General Anesthesia · China | 3 | Completed | Dec 31, 2020 | 129 |
| NCT04294056Anesthesia · China | 1 | Completed | Jun 22, 2020 | 18 |
| NCT04197661Healthy Elderly Subjects · China | 1 | Completed | Jan 22, 2020 | 32 |
| NCT04147416Sedation · China | 2 | Completed | May 31, 2020 | 39 |
| NCT04145583Anesthesia · China | 1 | Completed | Jan 6, 2020 | 16 |
| NCT04142970Renal Insufficiency, Chronic · China | 1 | Completed | Aug 4, 2020 | 24 |
| NCT04145596Hepatic Impairment · China | 1 | Completed | Apr 20, 2020 | 24 |
| NCT04111159Sedation or Anesthesia · China | 3 | Completed | Jun 19, 2020 | 267 |
| NCT04048811Induction and Maintenance of General Anesthesia · China | 2 | Completed | May 23, 2020 | 46 |
| NCT04037657Anesthesia | 1 | Completed | Jun 9, 2015 | 25 |
| NCT04054063General Anesthetic | 1 | Completed | Dec 21, 2016 | 25 |
| NCT04033939Anesthesia | 1 | Completed | Nov 11, 2014 | 48 |
| NCT04029766Anesthesia | 1 | Completed | Dec 14, 2015 | 13 |
| NCT03808844Induction of Anesthesia · China | 3 | Completed | Aug 14, 2019 | 178 |
| NCT03773835Anesthesia | 1 | Completed | Aug 2016 | 24 |
| NCT03773042Colonoscopy · China | 2 | Completed | Jun 2017 | 64 |
| NCT03758469Anesthesia · China | 1 | Completed | Jan 31, 2019 | 16 |
| NCT03751969Anesthesia | 1 | Withdrawn | Nov 1, 2020 | 0 |
| NCT03751956Anesthesia · China | 1 | Completed | Feb 28, 2019 | 6 |
| NCT03745625Anesthesia · China | 1 | Completed | Jul 2, 2019 | 16 |
| NCT03709056Sedation and Anesthesia for Adult Colonoscopy Procedures · China | 2 | Completed | Feb 2, 2018 | 94 |
| NCT03698617Induction of General Anaesthesia · China | 2 | Completed | Jun 29, 2018 | 114 |
| NCT03674008Sedation or Anesthesia · China | 3 | Completed | Jan 9, 2019 | 280 |
How it is read
Names in the registry
- “HSK3486”, 32 entries
- “Ciprofol”, 3 entries
- “Cipepofol”, 2 entries
- “HSK3486 0.1-0.2 /0.3 mg / kg group”, 1 entry
- “voriconazole +HSK3486”, 1 entry
Codes read as this program: HSK3486.
Conditions, from the studies’ own filings
- Arrhythmias, Cardiac, 1 study
- Renal Insufficiency, Chronic, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.